![Jeffrey Walsh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Walsh
Director/Board Member at
TENAYA THERAPEUTICS, INC.
Net worth: - $ as of 31/07/2026
Profile
Jeffrey T.
Walsh is currently Chief Executive Officer at Nvelop Therapeutics, Inc. since 2023, Chief Executive Officer & Director at nChroma Bio, Inc. since 2024, Independent Director at Tenaya Therapeutics, Inc. since 2020, Director at Tevard Biosciences, Inc. since 2018, and Advisor at Atlas Venture Advisors, Inc. Former roles include Senior Director-Corporate Finance at PathoGenesis Corp, Treasurer & Director at Alliance for Regenerative Medicine from 2018 to 2020, Vice President-Business Development at EXACT Sciences Corp., Vice President-Business Development at Allscripts LLC, Chief Business Officer & Executive Vice President at Inotek Pharmaceuticals Corp., Chief Financial & Business Officer at Taligen Therapeutics, Inc. from 2008 to 2011, Principal at GSK Plc, Chief Strategy Officer at Genetix Biotherapeutics, Inc. from 2019 to 2020, and Venture Partner at Third Rock Ventures LLC.
Education includes an undergraduate degree from Yale University in 1987 and an MBA from Kellogg School of Management in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Jeffrey Walsh active positions
| Companies | Position | Start |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Director/Board Member | 01/03/2020 |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases | Director/Board Member | 01/01/2018 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Nvelop Therapeutics, Inc.
 Nvelop Therapeutics, Inc. Personnel ServicesCommercial Services Provides recruitment services | Chief Executive Officer | 01/04/2023 |
Former positions of Jeffrey Walsh
| Companies | Position | End |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 11/02/2019 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 01/01/2020 |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Director of Finance/CFO | 01/02/2011 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | - |
| GSK PLC | Corporate Officer/Principal | - |
Training of Jeffrey Walsh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
EXACT Sciences Corp.
 EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
Allscripts LLC
 Allscripts LLC Packaged SoftwareTechnology Services Provides clinical software solutions | Technology Services |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tevard Biosciences, Inc.
Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases | Commercial Services |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Nvelop Therapeutics, Inc.
Nvelop Therapeutics, Inc. Personnel ServicesCommercial Services Provides recruitment services | Commercial Services |
- Stock Market
- Insiders
- Jeffrey Walsh
